Quarterly Results

  • Company Name :
Novartis India Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500672
  • NSE Symbol:
  • -
  • P/E(TTM):
  • 23.01
  • ISIN Demat:
  • INE234A01025
  • Div & Yield%:
  • 3.11
  • EPS(TTM):
  • 34.94
  • Book Value(₹):
  • 295.35
  • Market Cap(₹Cr.):
  • 1,985.39
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 83.88 93.00 87.11
Excise Duty 0.00 0.00 0.00
Net Sales 83.88 93.00 87.11
Other Operating Income 0.00 0.00 0.00
Other Income 10.63 10.60 10.32
Total Income 94.51 103.60 97.43
Total Expenditure 59.97 67.42 69.14
PBIDT 34.54 36.18 28.29
Interest 0.12 0.36 0.14
PBDT 34.42 35.82 28.15
Depreciation 0.53 0.53 0.59
Tax 3.84 9.77 8.22
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.75 0.07 -1.07
Reported Profit After Tax 29.30 25.45 20.41
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 29.30 25.45 20.41
EPS (Unit Curr.) 11.87 10.31 8.27
EPS (Adj) (Unit Curr.) 11.87 10.31 8.27
Calculated EPS (Unit Curr.) 11.87 10.31 8.27
Calculated EPS (Adj) (Unit Curr.) 11.87 10.31 8.27
Calculated EPS (Ann.) (Unit Curr.) 47.49 41.25 33.08
Calculated EPS (Adj) (Ann.) (Unit Curr.) 47.49 41.25 33.08
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 12.34 12.34 12.34
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 41.18 38.90 32.48
PBDTM(%) 41.03 38.52 32.32
PATM(%) 34.93 27.37 23.43